Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Nehlmeier

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Virology|November 4, 2016
Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM ProteinsFlorian Wrensch, Markus Hoffmann, Sabine Gärtner, et al.
Chemmedchem|November 30, 2025
Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl ThioureasMarco Minneci, Barbara Farkaš, Adeyemi Rahman, et al.
Plos One|April 12, 2019
Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsinsTeresa Plegge, Martin Spiegel, Nadine Krüger, et al.
Lancet (London, England)|August 20, 2021
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccinationGeorg Mn Behrens, Anne Cossmann, Metodi V Stankov, et al.
Vaccines|May 7, 2025
Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XECPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Plos One|December 8, 2017
The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cellsConstantin Brinkmann, Markus Hoffmann, Anastasia Lübke, et al.
Nanoscale|July 10, 2024
Probing scaffold size effects on multivalent lectin-glycan binding affinity, thermodynamics and antiviral properties using polyvalent glycan-gold nanoparticlesRahman Basaran, Darshita Budhadev, Amy Kempf, et al.
Plos One|November 5, 2019
Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaquesMichael Winkler, Sabine Gärtner, Lara Markus, et al.
The Lancet. Infectious Diseases|November 21, 2022
Omicron sublineage BQ.1.1 resistance to monoclonal antibodiesPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
The Journal of General Virology|May 18, 2019
Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesisRuth L O Lambertz, Ingo Gerhauser, Inga Nehlmeier, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Virology|November 4, 2016
Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM ProteinsFlorian Wrensch, Markus Hoffmann, Sabine Gärtner, et al.
Chemmedchem|November 30, 2025
Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl ThioureasMarco Minneci, Barbara Farkaš, Adeyemi Rahman, et al.
Plos One|April 12, 2019
Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsinsTeresa Plegge, Martin Spiegel, Nadine Krüger, et al.
Lancet (London, England)|August 20, 2021
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccinationGeorg Mn Behrens, Anne Cossmann, Metodi V Stankov, et al.
Vaccines|May 7, 2025
Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XECPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Plos One|December 8, 2017
The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cellsConstantin Brinkmann, Markus Hoffmann, Anastasia Lübke, et al.
Nanoscale|July 10, 2024
Probing scaffold size effects on multivalent lectin-glycan binding affinity, thermodynamics and antiviral properties using polyvalent glycan-gold nanoparticlesRahman Basaran, Darshita Budhadev, Amy Kempf, et al.
Plos One|November 5, 2019
Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaquesMichael Winkler, Sabine Gärtner, Lara Markus, et al.
The Lancet. Infectious Diseases|November 21, 2022
Omicron sublineage BQ.1.1 resistance to monoclonal antibodiesPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
The Journal of General Virology|May 18, 2019
Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesisRuth L O Lambertz, Ingo Gerhauser, Inga Nehlmeier, et al.
Pageof 8